Genprex, Inc. (GNPX)
2.20
+0.24
(+12.24%)
USD |
NASDAQ |
Feb 06, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Genprex SG&A Expense (TTM) : 6.261M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Arvinas, Inc. | 107.00M |
| Olema Pharmaceuticals, Inc. | 18.61M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Savara, Inc. | 37.38M |